share_log

康希諾生物：內幕消息 - 一致行動人的權益變動

CANSINOBIO: INSIDE INFORMATION - CHANGE OF INTERESTS OF PARTIES ACTING IN CONCERT

HKEX ·  Dec 13 21:05

Summary by Futu AI

康希諾生物宣佈董事會成員變動及股權結構調整。自2024年3月27日起，于玉、邱東旭及毛慧華將不再擔任公司董事職務，其任期將於2024年7月24日屆滿。公司股權結構也將發生變化，控股股東持股比例從31.29%降至28.07%。具體而言，于玉、邱東旭及毛慧華個人持股比例分別為7.26%、6.92%和6.60%，保持不變。然而，公司員工持股計劃所持有的3.23%股份將被撤銷。值得注意的是，毛慧華通過CHAMPDEN LLC和Medicharms LLC間接持有額外股份。此外，趙守白作為毛慧華的配偶，持有0.02%的公司股份。康希諾生物成立於2009年1月13日，于玉、邱東旭及毛慧華自2017年2月13日起擔任公司董事。公司於2018年5月24日在香港聯交所上市，股票代碼為06185。截至公告日期，于玉仍擔任公司CEO職務。這次董事會成員變動和股權結構調整可能對公司未來發展策略產生影響。
康希諾生物宣佈董事會成員變動及股權結構調整。自2024年3月27日起，于玉、邱東旭及毛慧華將不再擔任公司董事職務，其任期將於2024年7月24日屆滿。公司股權結構也將發生變化，控股股東持股比例從31.29%降至28.07%。具體而言，于玉、邱東旭及毛慧華個人持股比例分別為7.26%、6.92%和6.60%，保持不變。然而，公司員工持股計劃所持有的3.23%股份將被撤銷。值得注意的是，毛慧華通過CHAMPDEN LLC和Medicharms LLC間接持有額外股份。此外，趙守白作為毛慧華的配偶，持有0.02%的公司股份。康希諾生物成立於2009年1月13日，于玉、邱東旭及毛慧華自2017年2月13日起擔任公司董事。公司於2018年5月24日在香港聯交所上市，股票代碼為06185。截至公告日期，于玉仍擔任公司CEO職務。這次董事會成員變動和股權結構調整可能對公司未來發展策略產生影響。
CANSINOBIO announced changes in the Board of Directors and Shareholder Holdings. From March 27, 2024, Yu Yu, Qiu Dongxu, and Mao Huihua will no longer serve as directors of the company, with their terms expiring on July 24, 2024. The company's Shareholder Holdings will also change, with the controlling shareholder's ownership percentage decreasing from 31.29% to 28.07%.Specifically, the individual ownership percentages of Yu Yu, Qiu Dongxu, and Mao Huihua remain unchanged at 7.26%, 6.92%, and 6.60% respectively. However, the 3.23% shares held by the company's employee stock ownership plan will be canceled. Notably, Mao Huihua indirectly holds additional shares through CHAMPDEN LLC and Medicharms LLC. Furthermore, Zhao Shou Bai, as Mao Huihua's spouse, holds 0.02% of the company's shares.CANSINOBIO was established on January 13, 2009, and...Show More
CANSINOBIO announced changes in the Board of Directors and Shareholder Holdings. From March 27, 2024, Yu Yu, Qiu Dongxu, and Mao Huihua will no longer serve as directors of the company, with their terms expiring on July 24, 2024. The company's Shareholder Holdings will also change, with the controlling shareholder's ownership percentage decreasing from 31.29% to 28.07%.Specifically, the individual ownership percentages of Yu Yu, Qiu Dongxu, and Mao Huihua remain unchanged at 7.26%, 6.92%, and 6.60% respectively. However, the 3.23% shares held by the company's employee stock ownership plan will be canceled. Notably, Mao Huihua indirectly holds additional shares through CHAMPDEN LLC and Medicharms LLC. Furthermore, Zhao Shou Bai, as Mao Huihua's spouse, holds 0.02% of the company's shares.CANSINOBIO was established on January 13, 2009, and Yu Yu, Qiu Dongxu, and Mao Huihua have served as directors since February 13, 2017. The company was listed on the Hong Kong Stock Exchange on May 24, 2018, with the stock code 06185. As of the announcement date, Yu Yu still serves as the company's CEO. This change in the Board of Directors and Shareholder Holdings may impact the company's future development strategy.

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated